Science Editor Chapel Hill, N.C.-based start-up G-Zero Therapeutics hopes to grow by preventing cells from doing just that

Science Editor New research published this week showed that pulmonary fibrosis has underlying molecular mechanisms that are similar to those of liver fibrosis

Ditch Immunosuppressants After Kidney Transplants Researchers from Stanford University have worked out a regimen that allows kidney transplant patients to go off immunosuppressant drugs – a step that enables them to lead fuller lives whiles saving tens of thousands of dollars in immunosuppressant drug costs annually. The scientists led recipient immune systems to turning a blind eye to donated kidneys by giving them a twofold treatment: a conditioning regimen of lymph node irradiation plus T

Science Editor A study published last week showed how the eye protects itself from inflammatory damage – and how, when this process doesn't work well, disease can result

Science Editor One of the goals of regenerative medicine is to provide patients with autologous cell transplants to replace their own failing cells

BioWorld Today Science Editor A frequent challenge for drug developers is how to target drugs – especially cancer drug, which aim to kill their target cells – to the right cell population

Science Editor It is, of course, no great feat to predict that hepatitis C will be an important topic at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place in San Francisco in early November

Science Editor It seems quite likely that 2011 Nobelist Ralph Steinman will be remembered by more people than most uncontested winners...Editor's note: BioWorld Today's Science Editor Anette Breindl reflects on Ralph Steinman and his possible Nobel Prize in her blog post "Ralph Steinman Remembered: A Glimpse of Humility

30, 2011, issue of Cell. – Anette Breindl, Science Editor

Science Editor A frequent challenge for drug developers is how to target drugs – especially cancer drug, which aim to kill their target cells – to the right cell population

Science Editor Monoclonal antibodies are big business

BioWorld Today Science Editor One of the biggest challenges of RNA interference remains its delivery

Science Editor Researchers have identified an unexpected second role for a key protein that normally plays a role in cell division, in cells whose dividing days are long behind them

Epigenetic Changes: Easy Come, Easy Go Many things change in response to the environment, but DNA does not – the genes an individual is born with are the ones passed on to offspring, whether the offspring arrives days or decades later. Epigenetic changes, on the other hand, can be caused by the environment and passed on to the next generation, making them a mechanism for Lamarckian inheritance, or the inheritance of acquired traits. Now, researchers from the German Max-Planck-Institute of

Science Editor One of the biggest challenges of RNA interference remains its delivery

Science Editor British researchers published experiments today that challenge one of the more compelling scientific stories of the past decades: the idea that the enzyme Sir2, a member of an enzyme class known as the sirtuins, affects life span, and is activated by caloric restriction

BioWorld Today Science Editor First, the good news: In a medical system that will literally either cut costs or die trying, anti-infectives are one of the best deals around

Science Editor Bcr-Abl is the root cause of most cases of chronic myelogenous leukemia (CML) and the target of Gleevec (imatinib, Novartis AG) and several second-generation agents

Science Editor First, the good news: In a medical system that will literally either cut costs or die trying, anti-infectives are one of the best deals around